e-drug
[Top] [All Lists]

[e-drug] Will the European Court of Justice put a stop to the evergreening of Truvada patents?

E-DRUG: Will the European Court of Justice put a stop to the evergreening of 
Truvada patents?
---------------------------------------------------------------------------------------------

Dear e-drug readers,

Check out Pascale Boulet's latest blog on the issue of the Supplementary 
Protection Certificate in the EU:

Will the European Court of Justice put a stop to the ever-greening of Truvada 
patents?

https://medicineslawandpolicy.org/2018/05/will-the-european-court-of-justice-put-a-stop-to-the-evergreening-of-truvada-patents/
 

Introduction
Truvada, the fixed-dose combination of tenofovir disoproxil fumarate (TDF) and 
emtricitabine (FTC) is a critical medicine in both HIV treatment and 
prevention. It is used as pre-exposure prophylaxis (PrEP), which can reduce HIV 
transmission by over 90% in sero-discordant couples. Affordable pricing of the 
product is therefore important for public health.

Since July 2017, Truvada has been available in generic forms in some European 
countries (eg. the Netherlands, France) but not in others (eg. UK, 
Switzerland). This is because the key patent covering tenofovir disoproxil 
expired in July 2017 in most countries, but not in all. In Europe, some 
countries have extended the duration of the tenofovir patent beyond the 20-year 
patent term by granting a supplementary protection certificate (SPC).

Kind regards,

Ellen 't Hoen, LLM | Medicines Law & Policy
www.medicineslawandpolicy.org 
 ellenthoen@medicineslawandpolicy.net 
<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Will the European Court of Justice put a stop to the evergreening of Truvada patents?, Ellen 't Hoen <=